Shots: Pfizer acquires Therachon, in all stock transaction for $810M. Therachon to receive $340M upfront with additional payment on milestones of development and commercialization of its TA-46 candidate targeted for […]readmore
Tags : Therachon
Shots: Therachon gains exclusive commercialization and development rights to apraglutide, initially developed by Ferring Pharma and was exclusively licensed by GLyPharma in 2012. Novo Holdings to fund the transaction with […]readmore